| P50 | author | Amy Hauck Newman | Q76095333 |
| P2093 | author name string | Cindy Achat-Mendes | |
| | Donna M Platt | |
| | Roger D Spealman | |
| P2860 | cites work | Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and dis | Q48624409 |
| | Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys | Q48702113 |
| | Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities | Q48720196 |
| | Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. | Q48848853 |
| | Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. | Q51563929 |
| | Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes | Q51707373 |
| | Intravenous self-administration techniques in monkeys. | Q51958972 |
| | Intrinsic activity: partial agonists and partial antagonists | Q72695769 |
| | The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion | Q80098245 |
| | The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats | Q80605684 |
| | D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims | Q22010414 |
| | Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist | Q28141108 |
| | Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor | Q28305618 |
| | Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors | Q28584977 |
| | High-fat diet induced adiposity in mice with targeted disruption of the dopamine-3 receptor gene | Q28594901 |
| | Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists | Q31409124 |
| | Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. | Q33907064 |
| | The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered | Q33939745 |
| | Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys | Q33955144 |
| | Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands. | Q34188108 |
| | Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats | Q34222033 |
| | Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. | Q34297794 |
| | Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists | Q34374970 |
| | Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure | Q34390138 |
| | Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors | Q34414507 |
| | Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease | Q34429102 |
| | Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development | Q34954205 |
| | Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens | Q35682043 |
| | Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain | Q35904983 |
| | Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents | Q36139232 |
| | Is dopamine a physiologically relevant mediator of feeding behavior? | Q36866383 |
| | Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats | Q37052512 |
| | The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity | Q37189418 |
| | Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence | Q37363975 |
| | Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents | Q40098776 |
| | Dopamine receptor agonists, partial agonists and psychostimulant addiction | Q40562347 |
| | The D3 dopamine receptor: neurobiology and potential clinical relevance. | Q41602038 |
| | Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. | Q42557887 |
| | Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections | Q44273768 |
| | Altered feeding responses in mice with targeted disruption of the dopamine-3 receptor gene | Q44348441 |
| | Cocaine-Seeking Behavior in Response to Drug-Associated Stimuli in Rats: Involvement of D3 and D2 Dopamine Receptors | Q44407095 |
| | N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists | Q44472688 |
| | Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors | Q44557226 |
| | Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects | Q45161642 |
| | S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiologic | Q46462505 |
| | Modulation of cocaine self-administration in the rat through D-3 dopamine receptors | Q48266278 |
| | Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse | Q48337319 |
| | Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving | Q48421523 |
| P433 | issue | 1 | |
| P921 | main subject | dopamine | Q170304 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 73-84 | |
| P577 | publication date | 2009-06-10 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys | |
| P478 | volume | 206 | |